Responses of plasma catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide to exercise in patients with essential hypertension

Cardiology (Switzerland)

Volumn 88, Issue 3, 1997, Pages 238-245

  Kinugawa, T ^a   Endo, A ^a   Kato, M ^a   Kato, T ^a   Ahmmed, G U ^a   Omodani, H ^a   Osaki, S ^a   Ogino, K ^a   Hisatome, I ^a   Miyakoda, H ^a   Fujimoto, Y ^a   Yoshida, A ^a   Shigemasa, C ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Atrial natriuretic peptide; Essential hypertension; Exercise test; Plasma catecholamines; Renin angiotensin aldosterone; System

Indexed keywords

ADRENALIN; ALDOSTERONE; ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; CATECHOLAMINE; NEUROHORMONE; NORADRENALIN; RENIN;

ADRENALIN BLOOD LEVEL; ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CATECHOLAMINE BLOOD LEVEL; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; EXERCISE TEST; FEMALE; HEART FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TREADMILL EXERCISE;

EID: 0030948294     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000177336     Document Type: Article

References (47)

1. Kotchen TA. Hartley LH, Rice TW. Mougcy EH. Jones LG. Mason JW: Renin, norepinephrine. And epinephrine responses to graded exercise. J Appl Physiol 1971;31:178-184.
2. Stacssen J. Fagard R. Hcspel P. Lijncn P, Van-hees L. Amery A: Plasma renin system during exercise in normal men. J Appl Physiol 1987; 63:188-194.
3. Saito Y. Nakao K, Sugawara A. Nishiura K. Sakamoto M. Morii N. Yarnada T, Itoh H. Shiono S, Kuriyama T. Hirai M. Ohi M. Ban T, Imura H: Atrial natriuretic peptide during exercise in healthy man. Acta Endocrinol 1987; 111:59-65.
4. Rowell LB: Control of regional blood flow during dynamic exercise; in Rowell LB (cd): Human Cardiovascular Control. New York. Oxford University Press. 1993, pp 204-254.
5. Davies JO. Freeman RH: Mechanism regulating renin release. Physiol Rev 1976:56:1-56.
6. Ganguly A: Atrial natriuretic peptide-induced inhibition of aldosterone secretion: A quest for mcdiator(s). Am J Physiol 1992;263:E181-E194.
7. Johnston CI. Hodsman PG. Kohzuki M. Cas-ley DJ. Fabris B, Phillips PA: Interaction between atrial natriuretic peptide and the renin angiotensin aldosterone system. Am J Med 1989;87(suppl 6B):24S-28S.
8. Atlas SA. Volpe M. Sosa RF. Iaragh JH. Ca-margo MF. Maack T: Effects of atrial natriuretic factor on blood pressure and the renin-angio-lensin-aldosteronc system. Fed Proc 1986:45: 2115-2121.
9. Goldstein DS: Plasma catecholamines and essential hypertension: An analytical review. Hypertension 1983;5:86-99.
10. Goldstein DS. Lake CR: Plasma norepinephrine and epinephrine levels in essential hypertension. Fed Proc 1984;43:57-61.
11. Pedersen EB. Christensen NJ: Catecholamines in plasma and urine in patients with essential hypertension determined by double-isotope derivative techniques. Acta Med Scand 1975: 198:373-377.
12. Wyss JM: The role of the sympathetic nervous system in hypertension. Curr Opin Nephrol Hypertens 1993:2:265-273.
13. Brunner HR, Laragh JH. Baer L. Newton MA, Goodwin FT. Krakoff LR. Bard RH, Biihlcr FR: Essential hypertension: Renin and aldosterone, heart attack and stroke. N Engl J Med 1972:286:441-449.
14. Helmer OM: Renin activity in blood from patients with hypertension. Can Med Assoc J 1964:90:221-225.
15. Laragh JH, Baer I. Brunner HR. Bühler FR. Sealey JE, Vaughan ED Jr: Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease. Am J Med 1972;52:633-652.
16. Sealey JE. Blumcnfeld JD, Bell GM, Pecker MS. Sommers SC. Laragh JF: On the renal basis for essential hypertension: Nephron heterogeneity with discordant renin secretion and sodium excretion causing a hypertensive vasoconstriction-volume relationship. J Hypertens 1988:6:763-777.
17. Hollister AS. Inagami T: Atrial natriuretic factor and hypertension: A review and mctaanaly-sis. Am J Hypertens 1991.4:850-865.
18. Richards AM: Atrial natriuretic peptides and hypertension. J Intern Med 1994:253:543-560.
19. Atlas SA. Laragh JH: Atrial natriuretic factor and its involvement in hypertensive disorders: in Laragh JH. Brenner BM (cds): Hypertension: Pathophysiology. Diagnosis, and Management. New York. Raven Press, 1990, pp 861-883.
20. Sagnclla GA. Markandu ND, Shore AC, MacGregor GA: Raised circulating levels of atrial natriuretic peptides in essential hypertension. Lancet 1986;i: 179-181.
21. Luparini RL. Ferri C, Santucci A. Balsano F: Atrial natriuretic peptide in non-modulating essential hypertension. Hypertension 1993:21: 803-809.
22. Cody RJ. Kubo SH. Laragh JH. Atlas SA. Shaknovich A. Ryman K: Exercise-induced secretion of atrial natriuretic factor and its relation to hemodynamic and sympathetic stimulation in untreated essential hypertension. Am J Cardiol 1991:68:918-924.
23. Nishikimi T. Kohno M. Matsuura T. Kanaya-ma Y, Akioka K. Teragaki M. Yasuda M, Oku H. Takeuchi K. Takeda T: Circulating atrial natriuretic polypeptide during exercise in patients with essential hypertension. J Hperlens 1986;4(suppl 6):S546-S549.
24. Goldstein DS: Plasma norepinephrine during stress in essential hypertension. Hypertension 1981:3:551-556.
25. Saito Y. Nakao K, Sugawara A, Nishimura K. Morii N, Yamada T, Itoh H. Shiono S, Mu-koyama M. Arai H. Sakamoto M. Ban T. Imura H: Exaggerated secretion of atrial natriuretic polypeptide during dynamic exercise in patients with essential hypertension. Am Heart J 1988:116:1052-1057.
26. Jindra A Jr. Savlikova J. Bullas J: Relationship between plasma catecholamines and the renin-aldosterone system during exercise in normal and essential hypertensive subjects. Clin Exp Hypertcns 1990;A 12:415-435.
27. Teichholz LE, Kreulcn T, Herman MV, Gorlin R: Problems in échocardiographie volume determinations: Echocardiographie-angiographie correlations in the presence or absence of asynergy. Am J Cardiol 1976:37:7-11.
28. Sotobata I. Shino T, Kondo T. Tsuzuki J: Work intensities of different modes of exercise testings in clinical use. Jpn Cire J 1979:43:161-169.
29. Yui Y. Fujita T, Yamamoto T. Itokawa Y. Kawai C: Liquid chromatographic determination of norepinephrine and epinephrine in human plasma. Clin Client 1980:26:194-196.
30. Kinugawa T. Ogino K. Kitamura H. Miyakoda M. Saitoh M, Hasegawa J. Kotake H. Mashiba H: Response of sympathetic nervous system activity to exercise in patients with congestive heart failure. Eur J Clin Invest 1991:21:542-547.
31. Hama N, Nakao K. Nukouyama M. Suga S. Ogawa Y. Kawabata Y. Sugahara A. Imura H: Fundamental and clinical evaluation of Shion-oria" ANP. human atrial natriuretic peptide IRMA kit. Kiso to Rinsyo (Clin Rep) 1991:25: 455-462.
32. l2il] PRA Kit. Horumon toRinsyou 1980:28:63.
33. Morimoto T. Aoyama M. Goloh E. Shionoiri H: A method of radioimmunoassay of plasma angiotensin II using florisil. Folia Endocrinol Jap 1983:59:215-229.
34. Ogihara T. Iimura K. Nishi K. Arakawa Y. Takagi A, Kurata K. Miyai K, Kumahara Y: A non-chromatographic non-extraction radioimmunoassay for scrum aldosterone. J Clin Endocrinol Metab 1977:45:726-731.
35. Drayer JIM, Weber MA. Sealey JE, Laragh JH: Low and high renin essential HT: A comparison of clinical and biochemical characteristics. Am J MedSci 1981:281:135-142.
36. Laragh JH: Vasoconstriction-volume analysis for understanding and treating hypertension: The use of renin and aldosterone profiles. Am J Med 1973:55:261-274.
37. Montorsi P. Tonolo G, Polonia J, Hepburn D. Richards AM: Correlates of plasma atrial natriuretic factor in health and hypertension. Hypertension 1987:10:570-576.
38. Ganau A, Devereux RB. Atlas SA. Pecker M, Roman MJ. Vargiu P, Cody RJ. Laragh JH: Plasma atrial natriuretic factor in essential hypertension: Relation to cardiac size, function and systemic hemodynamics. Am J Coll Cardiol 1989:14:715-724.
39. Yamaji T. Ishibashi M. Sckihara H. Takaku F. Nakaoka H, Fujii J: Plasma levels of atrial natriuretic peptide in primary aldosteronism and essential hypertension. J Clin Endocrinol Metab 1987:63:815-818.
40. Laroehelle P. Cusson JR. Gutkowska J. Schif-frin EL. Hamel P. Kuchel O, Genest J, Cantin M: Plasma atrial natriuretic factor concentrations in essential and renovascular hypertension. Br Med J 1987:294:1249-1252.
41. Bolli P, Muller FB. Linder L, Raine AEG. Resink TJ. Erne P. Kiowski W. Buhler FR: Greater vasodilator responsiveness to atrial natriuretic peptide in low-renin essential hypertensives. J Hypertcns 1987;5(suppl 5):S55-S58.
42. Müller FB. Bolli P. Kiowski W. Erne P. Resink T. Raine AEG. Bühler FR: Atrial natriuretic peptide is elevated in low-renin essential hypertension. J Hypertcns 1986;4(suupl 6):S489-S491.
43. Sugawara A. Nakao K. Kono T. Morii N. Yamada T. Itoh H. Shiono S. Saito Y, Mukoyama M. Arai H. Imura H: Atrial natriuretic factor in essential hypertension and adrenal disorders. Hypertension 1988:1 (suppl I):1-212-1-216.
44. Kurtz A. Della-Bruna R. Pfeilschifter J. Taug-ner R. Bauer C: Atrial natriuretic peptide inhibits renin release from juxtaglomerular cells by a cGMP-mediated process. Proc Natl Acad Sei USA 1986:83:4769-4773.
45. Burnett JC Jr. Granger JP. Opgenoth TS: Effects of synthetic atrial natriuretic factor on renal function and renin release. Am J Physiol I984:247:F863-F866.
46. Chartier L. Schiffrin E. Thibault G. Gracia R: Atrial natriuretic factor inhibits the stimulation of aldosterone secretion by angiotensin II, ACTH and potassium in vitro and angiotensin ll-induced steroidogenesis in vivo. Endocrinology 1984:115:2026-2028.
47. Cunco RC. Espiner EA. Nicholls MG. Yandle TG. Livesey JH: Effect of physiological levels of atrial natriuretic peptide on hormone secretion: Inhibition of angiotensin-induced aldosterone secretion and renin release in normal man J Clin Endocrinol Metab 1987:65:765-772.